Latest Breaking News On - Prathamesh masdekar - Page 1 : comparemela.com

Dr Reddy s Q4FY24 Results: Consumer Health segment to drive growth of India Business; To focus on M&A opportunities in FY25 - Healthcare News

Dr Reddy s Q4FY24 Results: Consumer Health segment to drive growth of India Business; To focus on M&A opportunities in FY25 - Healthcare News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Prathamesh masdekarCenthaquine lyfaquinReddy laboratories ltdResearch analystAmyris incConsumer healthGovt run janaushadhiBranded marketsEmerging marketsFinancial expressGlobal generics

Indegene Listing: Stock expected to list at 40-65% premium over IPO price on May 13

Indegene Listing: Stock expected to list at 40-65% premium over IPO price on May 13
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

Prashanth tapsePrathamesh masdekarAmit goelResearch analystChief global strategist

Dr Reddy s Q4FY24 Results: Consumer Health segment to drive growth of India Business; To focus on M&A opportunities in FY25 - Pharma News

Dr Reddy s Q4FY24 Results: Consumer Health segment to drive growth of India Business; To focus on M&A opportunities in FY25 - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Centhaquine lyfaquinPrathamesh masdekarConsumer healthResearch analystAlembic pharmaceuticalsReddy laboratories ltdAmyris incOncology formulation facilityGland pharmaBranded marketsEmerging marketsFinancial expressGlobal generics

Dr Reddy s Q4 results: Profit up 36% at Rs 1,310 crore; Rs 40 dividend declared

Dr Reddy s Q4 results: Profit up 36% at Rs 1,310 crore; Rs 40 dividend declared
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Prathamesh masdekarParag agarwalResearch analyst at stoxboxDr reddy laboratories ltd onLaboratories ltdResearch analyst

Indegene IPO: Analyzing GMP, subscription status, and review for potential investors

Learn about the Indegene IPO, including subscription status, price band, analyst reviews, and more. Is this a viable investment opportunity? Find out now!

Amit goelLok sabhaPrathamesh masdekarIndegene limited initial public offeringLink intime india privateResearch analyst at stoxboxIndegene limitedInitial public offeringEconomic timesNon institutional investorResearch analystChief global strategistIndsec securitiesVentura securitiesIndegene ipo